flixotide nebules 0.5 mg/ 2ml nebuliser suspension
glaxosmithkline (ireland) limited - fluticasone propionate - nebuliser suspension - 0.5 mg/2ml - glucocorticoids; fluticasone
flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 250 µg/10 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flutiform 50 microgram/5 microgram per metered dose pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 50 µg/5 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flixotide nebules 0.5 mg/ 2ml nebuliser suspension
ltt pharma limited - fluticasone propionate - nebuliser suspension - 0.5 mg/2ml - glucocorticoids; fluticasone
flixotide nebules 2 mg/ 2 ml nebuliser suspension
ltt pharma limited - fluticasone propionate - nebuliser suspension - 2 mg/2ml - glucocorticoids; fluticasone
flutiform
mundipharma pty ltd - formoterol fumarate dihydrate, quantity: 0.8 mg; fluticasone propionate, quantity: 8 mg - inhalation, pressurised - excipient ingredients: ethanol absolute; sodium cromoglycate; apaflurane - flutiform inhaler is indicated for the regular maintenance treatment of asthma where the use of a combination product (an inhaled corticosteroid and a long-acting beta2-agonist) is appropriate. this includes patients not adequately controlled with inhaled corticosteroids and inhaled short-acting beta2-agonist on an ?as required? basis.
flutiform k-haler 125 microgram/5 microgram per actuation pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 125 µg/5 µg/actuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flutiform k-haler 50 microgram/5 microgram per actuation pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 50 µg/5 µg/actuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension
imed healthcare ltd. - fluticasone propionate; formoterol fumarate - pressurised inhalation, suspension - 250/10 µg/µg - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension
imed healthcare ltd. - fluticasone propionate; formoterol fumarate - pressurised inhalation, suspension - 125/5 µg/µg - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone